Rodger Elble, MD
Neurology · Springfield, ILNPI 1649251984
Payments from drug & device makers
Across 27 payments — averaging $1737.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Applied Therapeutics, Inc.$31K
- Sage Therapeutics, LLC$8K
- Jazz Pharmaceuticals Inc.$6K
- Osmotica Pharmaceutical Corp.$1K
- Neurocrine Biosciences, Inc.$450
- Eisai Inc.$49
- plus $116 from 3 others
Across 2 payments — averaging $787.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neurocrine Biosciences, Inc.$2K
What the payments were for
- Consulting fees$46,745100%
- Food & beverage$1220%
- Education$430%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Applied Therapeutics, Inc. | 7 | $31,100 |
| Sage Therapeutics, LLC | 8 | $7,605 |
| Jazz Pharmaceuticals Inc. | 5 | $6,465 |
| Osmotica Pharmaceutical Corp. | 1 | $1,125 |
| Neurocrine Biosciences, Inc. | 1 | $450 |
| Eisai Inc. | 1 | $49 |
| Medtronic | 1 | $43 |
| Merz North America, Inc. | 1 | $43 |
| Avion Pharmaceuticals | 2 | $30 |
How this compares
$46,910 in reported general payments places this provider in the 85th percentile of 790 neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RytaryCarbidopa/Levodopa | 24 | $41,646 |
| Carbidopa-Levodopa-EntacaponeCarbidopa/Levodopa/Entacapone | 18 | $7,666 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 117 | $5,089 |
| Selegiline Hcl | 52 | $3,737 |
| AmantadineAmantadine Hcl | 30 | $1,984 |
| Galantamine ErGalantamine Hbr | 14 | $1,926 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 13 | $1,904 |
| Propranolol Hcl ErPropranolol Hcl | 29 | $1,226 |
| Primidone | 24 | $1,221 |
| Quetiapine Fumarate | 28 | $705 |
| Donepezil Hcl | 47 | $604 |
| Fludrocortisone Acetate | 14 | $598 |
| Mirtazapine | 12 | $595 |
| Gabapentin | 15 | $465 |
| Sertraline Hcl | 19 | $292 |
Paid to pharmacies, not to this prescriber.
Other neurology in Springfield
- Thomas AlaSpringfield$2.4M
- Jennifer ArnoldSpringfield$787K
- Ahmad El KouziSpringfield$268K
- Daniel WynnNorthbrook$13.9M
- Concetta ForchettiElk Grove Village$8.5M
- Tatyana SimuniChicago$3.5M
- Danny BegaChicago$2.8M
- Augusto MiravalleChicago$2.1M
- Leonard Verhagen MetmanChicago$1.8M
- Anthony RederBurr Ridge$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.